Skip to main content
. Author manuscript; available in PMC: 2024 Jul 15.
Published in final edited form as: Lancet. 2023 Jun 5;402(10397):185–195. doi: 10.1016/S0140-6736(23)00922-4

Figure 1. Trial profile.

Figure 1.

All efficacy analyses were performed in the intention-to-treat population (all patients who were randomly assigned; n=522), and all safety analyses were performed in patients who received at least one dose of study drug (n=518).